IDEX operates through a decentralized model, focusing on high-margin, highly engineered solutions for niche markets. The company adheres to the 80/20 principle, identifying the 20% of products and customers that generate 80% of revenue, which minimizes complexity and improves profit margins.
Cyborg Score Rationale
IDEX receives a "Strong Buy" rating from 7 analysts with a 12-month price target of $228.86. The company has a portfolio of moaty businesses with leading share in niche end markets. However, valuations appear elevated relative to current growth rates.
Top Insights
Business organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products
As of February 2025, IDEX operated in approximately 20 countries and had approximately 9,000 employees
In Q1 2025, IDEX beat Wall Street estimates with strong demand in Health & Science Technologies segment
The company leverages its strong cash position for strategic M&A, acquiring smaller specialized firms as a cornerstone of its growth strategy
Named Competitors
Xylem — Water technology and infrastructure solutions
Parker Hannifin — Motion and control technologies
Eaton — Electrical and industrial components
SPX — Industrial equipment and solutions
Recent Developments
(July 2024) Announced acquisition of Mott Corp, a filtration products manufacturer, to strengthen health and science technologies segment
(Q2 2025) Posted revenue of $865.4 million (up 7.2% YoY) and adjusted EPS of $2.07, though lowered full-year adjusted EPS guidance
(Q1 2025) Beat Wall Street earnings and revenue estimates with strong demand in Health & Science Technologies
Open the full interactive IDEX Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.